AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.17) by 20.69 percent. This is a 16 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $1.54 million which missed the analyst consensus estimate of $1.98 million by 22.13 percent. This is a 102.61 percent increase over sales of $759.59 thousand the same period last year.